share_log

Stifel Upgrades Profound Medical to Buy, Raises Price Target to $12

Stifel Upgrades Profound Medical to Buy, Raises Price Target to $12

Stifel將Profound Medical升級爲買入評級,將目標價提高至12美元
Benzinga ·  07/16 05:30

Stifel analyst Rick Wise upgrades Profound Medical (NASDAQ:PROF) from Hold to Buy and raises the price target from $9 to $12.

Stifel分析師裏克·懷斯將Profound Medical(納斯達克股票代碼:PROF)從持有上調至買入,並將目標股價從9美元上調至12美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論